Experts emphasize the importance of informing states about clinical trials to ensure transparency and compliance with regulations. Clinical trials play a crucial role in testing the safety and efficacy of new drugs and treatments before they are made available to the public. However, experts argue that states should be more involved in the process to safeguard the interests of their residents. By keeping states informed about clinical trials, authorities can ensure that all necessary approvals and ethical considerations are in place. This approach can also help in addressing any concerns or issues that may arise during the trial phase. In India, where the pharmaceutical industry is rapidly growing, it is essential to have robust regulatory mechanisms in place to oversee clinical trials effectively. Experts suggest that collaboration between central and state governments, as well as regulatory bodies, is crucial to streamline the process and enhance transparency. Additionally, involving states in clinical trials can help in gathering more comprehensive data and insights that are representative of the diverse population in India. This, in turn, can lead to better healthcare outcomes for the entire country. Overall, experts stress the need for a collaborative and inclusive approach to conducting clinical trials in India to ensure the highest standards of safety and efficacy are met.